# Observational Fabry Disease studies recruiting: 30 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 30 trials that are observational for Fabry Disease that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting observational Fabry Disease studies: 30 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/observational/fabry-disease

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 30
- Recruiting or not yet: 30
- Read on: November 19, 2026

## Trials

The 25 newest of 30, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| May 8, 2026 | NCT07575347 | Periodontal Disease in Rare Renal Disorders (PERIO-RA-RE) | Sponsor not shown (see the record) | Observational | Recruiting | Periodontal Disease, Periodontitis, CKD, Chronic Kidney Disease, Alport Syndrome, Fabry Disease, Lupus or SLE, Tuberous... | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07575347) |
| March 20, 2026 | NCT07485660 | Care Pathway for Patients With Fabry's Disease (Fabry-PATH) | University Hospital, Toulouse | Observational | Not yet recruiting | Fabry Disease | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07485660) |
| February 2, 2026 | NCT07382128 | Myocardial Perfusion CMR for Differentiating and Characterizing Hypertrophic Cardiomyopathy Phenotypes | IRCCS Azienda Ospedaliero-Universitaria di Bologna | Observational | Recruiting | HCM - Hypertrophic Cardiomyopathy, Anderson Fabry Disease, Cardiac Magnetic Resonance Imaging, Amyloid Cardiomyopathy | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07382128) |
| January 20, 2026 | NCT07351136 | Novel Diagnostic and Prognostic Predictors in Fabry Cardiomyopathy: Proof of Concept in a Rare Disease | Sponsor not shown (see the record) | Observational | Not yet recruiting | Fabry Disease | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07351136) |
| January 13, 2026 | NCT07336394 | Precision Diagnosis and Risk Stratification of Rare Cardiomyopathies Based on Novel Cardiac Magnetic Resonance Techniques | Chinese Academy of Medical Sciences, Fuwai Hospital | Observational | Recruiting | Danon Disease, Fabry Disease, Cardiac Amyloidosis, Noonan Syndrome, Cardiac Sarcoidosis, Glycogen Storage Disease... | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07336394) |
| December 11, 2025 | NCT07277361 | Study of the Quality of Life of Patients With Fabry Disease Aged 65 and Over With and Without Specific Treatment | Sponsor not shown (see the record) | Observational | Recruiting | Fabry Disease, Aged 65 Years or Older, Alpha Galactosidase A Deficiency, Galactosidase A Gene Mutation | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07277361) |
| November 19, 2025 | NCT07235709 | Effect of Agalsidase Alfa on Cardiac Inflammation in Patients With Fabry Disease: A \[18F\]-FDG PET-CMR Study | Yonsei University | Observational | Recruiting | Fabry Disease | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07235709) |
| September 23, 2025 | NCT07187440 | A Study of Agalsidase Alfa Enyzme Replacement Therapy in Chinese Children and Adults With Fabry Disease | Takeda | Observational | Recruiting | Fabry Disease | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07187440) |
| August 7, 2025 | NCT07109375 | Observational Study on Long-term Use of Pegunigalsidase Alfa in Fabry Patients in a Real-world Setting | Sponsor not shown (see the record) | Observational | Recruiting | Fabry Disease | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07109375) |
| May 4, 2025 | NCT06956573 | Aortic Dimensions in Patients With Fabry Disease | University Hospital, Caen | Observational | Not yet recruiting | Fabry Disease | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06956573) |
| April 23, 2025 | NCT06941025 | Maternal and Postnatal Outcomes Study (MOS): A Global Observational Registry Assessing the Safety of Elfabrio® in Women With Fabry Disease... | Chiesi Farmaceutici S.p.A. | Observational | Recruiting | Fabry Disease, Pregnancy, Pregnancy Complications | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06941025) |
| April 2, 2025 | NCT06906367 | A Study of Patients With Fabry Disease (US Specific) | Amicus Therapeutics | Observational | Recruiting | Fabry Disease | 450 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06906367) |
| March 19, 2025 | NCT06884358 | Functional Capacity in Anderson-Fabry Disease Patients | IRCCS Policlinico S. Donato | Observational | Recruiting | Anderson-Fabry Disease | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06884358) |
| February 7, 2025 | NCT06813443 | Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac Transplantation | IRCCS Azienda Ospedaliero-Universitaria di Bologna | Observational | Recruiting | Cardiomyopathies, Amyloidosis Cardiac, Fabry Disease, Arrhythmogenic Cardiomyopathy, Hypertrophic Cardiomyopathy (HCM)... | 700 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06813443) |
| February 4, 2025 | NCT06806813 | Italian Anderson Fabry Disease Cardiovascular Registry | IRCCS Azienda Ospedaliero-Universitaria di Bologna | Observational | Recruiting | Fabry Disease | 800 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06806813) |
| January 15, 2025 | NCT06776419 | the Role of cArdiac Inflammation, endoThelial Dysfunction, and FIbrosis in fabrY Disease | Sponsor not shown (see the record) | Observational | Recruiting | Fabry Disease, Cardiovascular Diseases | 54 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06776419) |
| January 6, 2025 | NCT06758648 | Characterizing the Retinal Microvasculature in Patients with Fabry Disease: a Prospective Observational Study | Technical University of Munich | Observational | Recruiting | Fabry Disease, Endothelial Dysfunction, Microvasculature | 63 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06758648) |
| October 29, 2024 | NCT06663358 | A Multi-Country Observational Study of Safety and Effectiveness of Elfabrio® in Fabry Patients | Chiesi Farmaceutici S.p.A. | Observational | Recruiting | Fabry Disease | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06663358) |
| September 24, 2024 | NCT06610019 | Cardiovascular Multimodality Imaging Study | Montefiore Medical Center | Observational | Recruiting | Non-ischemic Cardiomyopathy, Cardiomyopathies, Hypertrophic Cardiomyopathy, Right Ventricular Arrhythmogenic... | 10,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06610019) |
| September 23, 2024 | NCT06607471 | Multimodal and Multidisciplinary Approach to Optimize Diagnostic, Prognostic, and Therapeutic Management of Patients with Non-ischemic... | Scientific Institute San Raffaele | Observational | Recruiting | Non-ischemic Cardiomyopathy, Dilated Cardiomyopathy (DCM), Hypertrophic Cardiomyopathy (HCM), Restrictive... | 15,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06607471) |
| July 22, 2024 | NCT06512571 | CVI Alterations in FD: a Prospective, Multicenter, Observational Cohort Study | China National Center for Cardiovascular Diseases | Observational | Recruiting | Fabry Disease, Cardiac Variant | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06512571) |
| March 22, 2024 | NCT06325488 | Fibrosis, Inflammation, Oxygenation of Renal Tissue In FabrY Disease | Sponsor not shown (see the record) | Observational | Recruiting | Fabry Disease, Chronic Kidney Diseases | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06325488) |
| October 4, 2023 | NCT06065852 | National Registry of Rare Kidney Diseases | UK Kidney Association | Observational | Recruiting | Adenine Phosphoribosyltransferase Deficiency, AH Amyloidosis, AHL Amyloidosis, AL Amyloidosis, Alport Syndrome... | 35,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06065852) |
| January 26, 2023 | NCT05698901 | Biomarkers and Cardiac Imaging Diagnostic Assay for Monitoring Patients With Fabry Disease | Mackay Memorial Hospital | Observational | Recruiting | Fabry Disease | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05698901) |
| July 26, 2022 | NCT05473637 | Taiwan Associated Genetic and Nongenetic Small Vessel Disease | National Taiwan University Hospital | Observational | Recruiting | Cerebral Small Vessel Diseases, Cadasil, HTRA1-Related Autosomal Dominant Cerebral Angiopathy, COL4A1-Related Brain... | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05473637) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 3 |
| [Chiesi Farmaceutici S.p.A.](https://specstream.ai/data/clinical-trials/company/chiesi-farmaceutici-s-p-a) | 2 |
| [Amicus Therapeutics](https://specstream.ai/data/clinical-trials/company/amicus-therapeutics) | 2 |
| Mackay Memorial Hospital | 1 |
| [Genzyme, a Sanofi Company](https://specstream.ai/data/clinical-trials/company/genzyme-a-sanofi-company) | 1 |
| Scientific Institute San Raffaele | 1 |
| China National Center for Cardiovascular Diseases | 1 |
| Chinese Academy of Medical Sciences, Fuwai Hospital | 1 |
| University of Minnesota | 1 |
| Montefiore Medical Center | 1 |
| Yonsei University | 1 |
| National Taiwan University Hospital | 1 |
| University Hospital, Caen | 1 |
| UK Kidney Association | 1 |
| Technical University of Munich | 1 |
| University Hospital, Toulouse | 1 |
| [Takeda](https://specstream.ai/data/clinical-trials/company/takeda) | 1 |
| Wuerzburg University Hospital | 1 |
| IRCCS Policlinico S. Donato | 1 |
| Canadian Fabry Research Consortium | 1 |

## By country

| Country | Trials |
| --- | --- |
| Italy | 8 |
| United States | 7 |
| China | 4 |
| Germany | 4 |
| United Kingdom | 4 |
| Denmark | 3 |
| Taiwan | 3 |
| France | 3 |
| Canada | 2 |
| Romania | 2 |
| South Korea | 2 |
| Spain | 2 |
| Argentina | 1 |
| Australia | 1 |
| Belgium | 1 |
| Brazil | 1 |
| Bulgaria | 1 |
| Chile | 1 |
| Colombia | 1 |
| Croatia | 1 |
| Czechia | 1 |
| Estonia | 1 |
| Finland | 1 |
| Hong Kong | 1 |
| Hungary | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Fabric wholesalers in the United States](https://specstream.ai/data/businesses/fabric-wholesalers/united-states)
- [Tractor dealers in the United States](https://specstream.ai/data/businesses/tractor-dealers/united-states)
- [Hospitals in the United States](https://specstream.ai/data/businesses/hospitals/united-states)
- [American restaurants in the United States](https://specstream.ai/data/businesses/american-restaurants/united-states)
- [Marble and granite professional companies in the United States](https://specstream.ai/data/businesses/marble-and-granite-professional-companies/united-states)
- [Blinds and shades companies in the United States](https://specstream.ai/data/businesses/blinds-and-shades-companies/united-states)
